TSE:NVLN Novelion Therapeutics Inc, (NVLN) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free NVLN Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$13.30▼C$13.3052-Week Range N/AVolume3,639 shsAverage Volume3,220 shsMarket CapitalizationC$251.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Novelion Therapeutics Inc, alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Novelion Therapeutics Inc,Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… NVLN Stock News HeadlinesMarch 24, 2024 | morningstar.comCentury Therapeutics Inc IPSCFebruary 14, 2024 | wsj.comCymaBay Therapeutics Inc.March 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 6, 2024 | investing.comAclaris Therapeutics Inc (ACRS)January 3, 2024 | investing.comHighTide Therapeutics Inc (2511)December 30, 2023 | investing.comIntensity Therapeutics Inc (INTS)December 17, 2023 | morningstar.comLeap Therapeutics Inc LPTXNovember 14, 2023 | morningstar.comAileron Therapeutics Inc ALRNMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.November 11, 2023 | morningstar.comAtossa Therapeutics Inc ATOSNovember 1, 2023 | morningstar.comBeam Therapeutics Inc BEAMNovember 1, 2023 | morningstar.comAprea Therapeutics Inc APRENovember 1, 2023 | morningstar.comCelldex Therapeutics Inc CLDXOctober 31, 2023 | morningstar.comCARISMA Therapeutics Inc CARMSeptember 29, 2023 | finance.yahoo.comIs Viking Therapeutics, Inc. a Buy?August 26, 2023 | seekingalpha.comIMUN Immune Therapeutics, Inc.August 24, 2023 | seekingalpha.comELVN Enliven Therapeutics, Inc.May 10, 2023 | morningstar.comSigilon Therapeutics Inc Ordinary SharesApril 25, 2023 | finance.yahoo.comSarepta Therapeutics, Inc. (SRPT)April 20, 2023 | morningstar.comNurix Therapeutics Inc Ordinary SharesApril 20, 2023 | seekingalpha.comZVSA ZyVersa Therapeutics, Inc.March 26, 2023 | finanznachrichten.deDefence Therapeutics Inc.: Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 MillionFebruary 26, 2023 | benzinga.comWindtree Therapeutics Stock (NASDAQ:WINT), Quotes and News SummaryJanuary 28, 2023 | seekingalpha.comFDMT 4D Molecular Therapeutics, Inc.January 27, 2023 | seekingalpha.comAVTE Aerovate Therapeutics, Inc.January 24, 2023 | seekingalpha.comRUBY Rubius Therapeutics, Inc.January 24, 2023 | seekingalpha.comCOEP Coeptis Therapeutics Holdings, Inc.See More Headlines Receive NVLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novelion Therapeutics Inc, and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolTSE:NVLN Previous SymbolTSE:QLT CUSIPN/A CIKN/A Webwww.novelion.com Phone+1-604-7077000FaxN/AEmployees109Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares18,932,000Free FloatN/AMarket CapC$251.80 million OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key CompetitorsImvescor Restaurant GroupTSE:IRGRedknee SolutionsTSE:RKNHalogen SoftwareTSE:HGNTIO NetworksCVE:TNCAMI.TOTSE:AMIView All Competitors NVLN Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Novelion Therapeutics Inc, own? Based on aggregate information from My MarketBeat watchlists, some companies that other Novelion Therapeutics Inc, investors own include Alnylam Pharmaceuticals (ALNY), NXP Semiconductors (NXPI), Whole Foods Market (WFM), InvenSense (INVN), OPKO Health (OPK), Vitamin Shoppe (VSI), Aurora Cannabis (ACB), ABGBY (ABGBY), Gilead Sciences (GILD) and 3D Systems (DDD). How do I buy shares of Novelion Therapeutics Inc,? Shares of NVLN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NVLN) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novelion Therapeutics Inc, Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.